Chow Wei Too - Concepedia

Author

Chow Wei Too

Singapore General Hospital ORCID

Also Known As

C Too, C. Too, C. Wei Too, C.W. Too, Choon Boon Too, Chow Wei Too

118

Publications

Citations

H-Index

Concepts

All Affiliations

Singapore General Hospital National Cancer Centre Singapore Duke-NUS Medical School National University of Singapore Genome Institute of Singapore

About

Chow Wei Too is an author at Singapore General Hospital specializing in medicine, radiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Health Sciences	4	4	209
3	Hepatology	4	4	209
4	Medical Laboratory Science	2	2	57
5	Gastroenterology	1	1	32

Chow Wei Too

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Genomic landscape of lung adenocarcinoma in East Asians Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Nature Genetics PathologyCancer GenomicsBronchial NeoplasmEast AsiansMedicine	2020	517
CIRSE Guidelines on Percutaneous Vertebral Augmentation Georgia Tsoumakidou, Chow Wei Too, Guillaume Koch, CardioVascular and Interventional Radiology Cirse GuidelinesVascular SurgerySurgerySpine DeformitySpine Surgery	2017	176
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis Aaron C. Tan, Gillianne Lai, Gek San Tan, Lung Cancer Cost-effectiveness AnalysisMedicineNext-generation SequencingPathologyCancer Genomics	2019	117
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna, The Lancet. Gastroenterology & hepatology HepatologyHepatocellular CarcinomaSingle ArmMedicineY90-resin Microspheres	2021	117
Clonal <i>MET</i> Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer Gillianne Lai, Tse Hui Lim, John Lim, Journal of Clinical Oncology	2019	116
Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty Farah Gillan Irani, T. Teo, Kiang Hiong Tay, Radiology	2018	98
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma Pierce K. H. Chow, Su Pin Choo, David Chee Eng Ng, Liver Cancer	2016	52
A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678. Wai Meng David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna, Journal of Clinical Oncology Phase Ii Open-labelY90-re FieldPathologyNonrandomized TrialOncology	2020	38
Randomized Controlled Trial Comparing Drug-coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial Ankur Patel, Farah Gillan Irani, Uei Pua, Radiology	2021	37
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities Khi Pin Chua, Yvonne H.F. Teng, Aaron C. Tan, Clinical Cancer Research	2021	36

Page 1